Cargando…
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
BACKGROUND: STAT3 [1] has been shown to be dysregulated in nearly every major cancer, including osteosarcoma (OS). Constitutive activation of STAT3, via aberrant phosphorylation, leads to proliferation, cell survival and resistance to apoptosis. The present study sought to characterize the biologic...
Autores principales: | Couto, Jason I, Bear, Misty D, Lin, Jiayuh, Pennel, Michael, Kulp, Samuel K, Kisseberth, William C, London, Cheryl A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585923/ https://www.ncbi.nlm.nih.gov/pubmed/23244668 http://dx.doi.org/10.1186/1746-6148-8-244 |
Ejemplares similares
-
Characterization of STAT3 activation and expression in canine and human osteosarcoma
por: Fossey, Stacey L, et al.
Publicado: (2009) -
Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
por: Bid, Hemant K., et al.
Publicado: (2012) -
Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011) -
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
por: Fenger, Joelle M., et al.
Publicado: (2016) -
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011)